McDonnell Barry J, Beaney Thomas, Al Shezawi Mahfoudha, Cockcroft John R, Barciela Carolina, Tay Tricia, Keitley James, Brady Adrian J B, Padmanabhan Sandosh, McCallum Linsay, Dolan Eamon, O'Brien Eoin, Tomaszewski Maciej, Schutte Aletta E, Poulter Neil R, Cappuccio Franco P
Department of Biomedical Sciences, Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Cardiff CF5 2YB, UK.
Imperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Eur Heart J Suppl. 2020 Aug;22(Suppl H):H132-H134. doi: 10.1093/eurheartj/suaa047. Epub 2020 Aug 28.
Raised blood pressure (BP) was the biggest contributor to the global burden of disease in 2017, with lack of awareness and adequate control of BP identified as the main drivers of this disease burden. In 2017, an opportunistic BP screening and awareness campaign called May Measurement Month (MMM) in the UK and Republic of Ireland (RoI) highlighted that levels of undiagnosed hypertension and uncontrolled hypertension in the community screened were approximately 23% and 40%, respectively. MMM18 was undertaken to further the campaign's efforts to increase awareness and create an evidence base of population risk associated with high BP. MMM18 BP screenings were conducted in the community at places of worship, supermarkets, GP surgeries, workplaces, community pharmacies, gyms, and various other public places. A total of 5000 volunteers, aged 47.3 (±17.2) years, 60% female were screened. Of all 5000 individuals screened, 1716 (34.3%) were hypertensive, of which only 51.3% were aware of their condition, 42.8% on antihypertensive treatment, and only 51.5% of those on medication controlled to target BP of <140/90 mmHg. Furthermore, obese, overweight, and underweight participants all had significantly higher BP values compared to individuals with a healthy body mass index (BMI). The 2018 MMM campaign in the UK and the RoI confirmed approximately one in three adults were hypertensive, with more than half having uncontrolled BP. In addition, these findings show that people with low BMI are at risk of having high BP. Finally, with only one in two people aware of their high BP, awareness remains a significant public health concern.
高血压是2017年全球疾病负担的最大促成因素，血压缺乏认知和未得到充分控制被确定为这种疾病负担的主要驱动因素。2017年，英国和爱尔兰共和国开展了一项名为“五月测量月”（MMM）的机会性血压筛查和宣传活动，该活动强调，在接受筛查的社区中，未诊断高血压和未控制高血压的比例分别约为23%和40%。开展MMM18活动是为了进一步推动该活动提高认知度的努力，并建立与高血压相关的人群风险证据基础。MMM18血压筛查在社区的宗教场所、超市、全科医生诊所、工作场所、社区药房、健身房和其他公共场所进行。共有5000名志愿者接受了筛查，他们的年龄为47.3（±17.2）岁，女性占60%。在所有5000名接受筛查的个体中，1716人（34.3%）患有高血压，其中只有51.3%的人知晓自己的病情，42.8%的人正在接受抗高血压治疗，而在接受药物治疗的人中，只有51.5%的人血压控制在<140/90 mmHg的目标值。此外，与身体质量指数（BMI）健康的个体相比，肥胖、超重和体重过轻的参与者血压值均显著更高。英国和爱尔兰共和国2018年的MMM活动证实，约三分之一的成年人患有高血压，其中一半以上的人血压未得到控制。此外，这些研究结果表明，BMI较低的人有患高血压的风险。最后，只有二分之一的人知晓自己患有高血压，认知问题仍然是一个重大的公共卫生问题。
